Page 5 - Best Brain MRI doctors in Turkey: TOP 145 doctors

Education

2019

Istanbul Faculty of Medicine, Electroneurophysiology

2005

Istanbul University Cerrahpasa Faculty of Medicine, Neurology

1998

Istanbul University Cerrahpasa, Faculty of Medicine

Experience

2017 - 2019

Private Adatip Kurtkoy Hospital

2016

TND – Schering-Plough Proceedings of the Year Awards

2015 - 2017

Istanbul Yeni Yüzyıl University Private Gaziosmanpaşa Hospital

2015 - 2015

Şişli Hamidiye Etfal Training and Research Hospital

2005 - 2014

Private Avicenna Hope Hospital

2015 – 2019 Istanbul University Cerrahpasa Faculty of Medicine

2019 – Medipol University Pendik Hospital

Publications

1- Yüz Ağrılarında Trigeminal SEP Uygulaması ; Yüksek Lisans Tezi

2- Glial Tümörlerde P53 , PTEN ve EGRF Pozitifliğinin İmmunohistokimyasal ; Uzmanlık Tezi

3- Two siblings with homocystinuria presenting with dystonia and parkinsonism

4- Lack of association between IL-1ß/? gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis

5- Psychogenic movement disorders in two children

6- Temporal Lob Epilepsi ve Hippokampal Sklerozlu Hastalarda İnterlökin 1-ß ve İnterlökin 1-? Gen Polimorfizminin Analizi

7- Hippokampal Skleroza Bağlı Mesial Temporal Lob Epilepsisi İle İnterlökin 1-ß ve İnterlökin 1-? Gen Polimorfizmi İlişkisinin Araştırılması

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

General Information and Presentation

He completed his primary education at Şenlikköy Primary School and his secondary education at the Istek Foundation Florya Bilge Kagan High School. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 2001. He completed his specialist education in Istanbul Medical Faculty Neurology Department in 2006. In 2006 he worked at the Neurology Clinic and the PharmaZentrum Research Center of the Faculty of Medicine of the University of Basel, Switzerland. Between 2007 and 2011, Bakırköy Prof. Dr. He worked at Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital in the 3rd Neurology Clinic and in the Dementia and Movement Disorders policlinics. Since October 2011, he has been working at Istanbul University of Science, Faculty of Medicine, Neurology, USA.

Experience

İstanbul Bilim University Faculty of Medicine Neurology, 

Şişli Florence Nightingale Hospital 

Kadıköy Florence Nightingale Hospital Neurology Clinics, 

Gayrettepe Metropolitan Florence Nightingale Hospital PET department.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Experience

2019 – 2019

• University of Insubria, Varese, Italy, 

Insubria University Faculty of Medicine

2015

• MERSİN UNIVERSITY/FACULTY OF MEDICINE, DOCTOR, LECTURER

2013 – 2015

• ANKARA PRIVATE ACIBADEM HOSPITAL

2010 – 2012

• DIYARBAKIR TRAINING AND RESEARCH HOSPITAL,

2002 – 2003

• AYDIN 1ST PRIVATE TRAINING BATTALION
•  

Education

2010

• ANKARA UNIVERSITY FACULTY OF MEDICINE, BRAIN AND SURGERY SPECIALIST

1992

• GAZI UNIVERSITY, FACULTY OF MEDICINE

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Dr. Mehmet Osman Akcakaya is a neurosurgeon with 18 years of experience. He specializes in microneurosurgery and functional neurosurgery. He treats head trauma, brain tumors, Parkinson’s disease, and spinal disorders. Dr. Akcakaya uses advanced surgical techniques for these complex conditions.

He has received several awards, including the Second Prize for 'Best Oral Presentation' at the Congress of the Nervous System Surgery Society. He completed a 4-year training program with the European Association of Neurosurgical Societies (EANS). He also holds the EANS board certificate (Part I). Dr. Akcakaya has completed fellowships in Israel and Germany.

He is a member of the Turkish Association of Neurosurgery and EANS. He has also served on scientific committees for international courses on endoscopic spine surgery.

Dr. Mustafa Kilic is a skilled neurosurgeon with expertise in neuromodulation. He performs Deep Brain Stimulation, Spinal Cord Stimulation, and Sacral Nerve Stimulation. Dr. Kilic manages all stages of patient care, from preoperative evaluation to postoperative follow-up. He focuses on achieving the best possible outcomes for his patients.

Dr. Kilic is an Associate Professor at Istinye University. He is active in neurosurgery research and education. As a member of the Turkish Neurosurgical Society, he has completed many advanced neuromodulation procedures. His work has led to high patient satisfaction and strong results in complex neurological cases.

Professional Experience Compulsory Service 2014 - 15 District Health Director - Güroymak Community Health Center/BİTLİS Specialization 2015 - 20 Fırat University Faculty of Medicine, Department of Neurosurgery. Work Location 2024 - present Eskişehir City Hospital Neurosurgery Department Education Siirt Ataturk Anatolian High School 2003 - 07 Fırat University Faculty of Medicine 2007 - 13 SCIENTIFIC ARTICLES • 1. Ozturk S, Erol FS, Akgun B, Surme MB, Artas G, Ozercan IH. Intradural Extramedullary Spinal Cavernous Hemangioma Mimicking Neurofibroma in a Patient Diagnosed with Neurofibromatosis Type I. Turkish Journal of Neurosurgery 2016; 26:141-144. • 2. Akgun B, Ozturk S, Taskent I, Surme MB, Erol FS, Yildirim H. Evaluation of Apparent Diffusion Coefficients in the Cerebellar Tonsils and Bulbus in Chiari Type I Malformations: Comparison Before and After Surgery. Turk Neurosurg. 2017 May 7. • 3. Surme MB, Hergünsel OB, Ertugrul B, Kaplan M. Ossifying Chronic Subdural Hematoma. Turkiye Clinicals Journal of Neurology. 2017;12:44-48 • 4. Akgun B, Surme MB, Ozturk S, Erol FS. Spontaneous Spinal Epidural Hematomas: Evaluation of 12 Cases. F.U. Journal of Health Science and Medicine. 2016; 30:107-111. • 5. Surme MB, Hergunsel OB, Akgun B, Kaplan M. Cranioplasty with preoperatively customized Polymethyl-methacrylate by using 3-Dimensional Printed Polyethylene Terephthalate Glycol Mold. J Neurosci Neurol Disord. 2018; 2:052-064. • 6. Bakal U, Poyraz AK, Tartar T, Akdeniz I, Surme MB, Çelik S. A Rare Complication of Ventriculoperitoneal Shunt: Asymptomatic Small Bowel Perforation Istanbul Med J 2019; 20(6): 571-3. • 7. De Lima L, Surme MB, Gessi M, Mastronuzzi A, Miele E, Tamburrini G, Massimi L. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)—case-based reviews Child's Nervous System ( 2020) 36:1589–1599 • 8. Surme MB, Demir F, Erol D., Kaplan M. Is There A Genetic Relationship Between Acute Lymphoblastic Leukemia And Meningioma ? A Case Report Of 3 Genes Analyzes. Arq Bras Neurocir 2021;00:1–3. • 9. Gurbuz O, Surme MB. The effect of intradiscal percutaneous radiopaque gel ethanol injection on pain in patients with lumbar disc herniation: Our clinical experience. Eskisehir Med. J. 2022; 3(2):130-137. • 10. Arikan E, Surme MB. Evaluation of Clinical and Radiological Findings of Patients Diagnosed with Spontaneous Intracerebral Hematoma. Mevlana Medical Sciences Journal 2 (2), 70-74. ORAL PRESENTATIONS • Hergünsel OB, Ertugrul B, Surme MB, Kaplan M. A Case of Cervicogenic Headache Treated with C1 Posterior Arch Resection. Turkish Journal of Neurosurgery 30th Scientific Congress, 8-12 April 2016, Antalya. • Ozturk S, Erol FS, Akgun B, Surme MB, Artas G, Ozercan İH. Intradural Extramedullary Spinal Cavernous Hemangioma Mimicking Neurofibroma in a Patient Diagnosed with Neurofibromatosis Type I. Turkish Neurosurgery Society 30th Scientific Congress. 8-12 April 2016, Antalya. • Ertugrul B, Surme MB, Ozturk S, Kaplan M. A Case of Sacrococcygeal Teratoma Presenting with Intergluteal Tail. Turkish Neurosurgery Society 30th Scientific Congress. 8-12 April 2016, Antalya. • Akgun B, Surme MB, Ozturk S, Demir F, Okcesiz I, Erol FS. Evaluation of Acute Lumbar Disc Hernias with Thin Section Lumbar MRI. 12th International Turkish Spine Congress, 19-22 April 2017, Antalya. • Akgun B, Ozturk S, Taskent I, Surme MB, Erol FS, Yildirim H. Evaluation of Apparent Diffusion Coefficients in the Cerebellar Tonsils and Bulbus in Chiari Type I Malformations: Comparison Before and After Surgery. XVI. World Congress of Neurosurgery, August 20-25, 2017, Istanbul. • Akgun B, Surme MB, Ozturk S, Erol FS. Spontaneous Spinal Epidural Hematomas: Evaluation of 12 Cases. 12th International Turkish Spine Congress. 19-22 April 2017, Antalya. • Surme MB, Hergunsel OB, Celik S., Kaplan M, Erol FS. Evaluation of Cases with Cervical Spondylomyelopathy who underwent corpectomy - Our Clinical Experience. Turkish Neurosurgery Society 32nd Scientific Congress. 20-24 April 2018, Antalya. • Surme MB, Hergunsel OB, Akgun B, Kaplan M. Repair of Orbitofrontal Defects Using Polymethylmethacrylate Grafts Created by 3D Printer. Turkish Neurosurgery Society 32nd Scientific Congress. 20-24 April 2018, Antalya. C I T A T I O N S • My publications have a total of 40 citations. CERTIFICATES (OTHER) • 1. I received an Academic Incentive Bonus for 1 year in 2017 for my academic publications. • 2. Community Health Center Physicians Education. 14-18 July 2014, Kars. (Turkish public health institution). • 3. V. Turkey Zoonotic Diseases Symposium. 24 October 2015, Erzurum. (EKMUD- Turkish Infectious Diseases Specialization Association and TVHB - Turkish Veterinary Medical Association). • 4. Meaningful Occupation Solutions Together. 15-17 April 2015, Gothenburg/Sweden. (Lifelong Learning Programme). • 5. Certificate of Achievement (Position: District Health Manager) 2015, Güroymak/ Bitlis • (Güroymak District Governorship) • 6. Between 16.03.2019 - 04.04.2019, I performed my military service in Mamak/Ankara and was given a 'Certificate of Appreciation'. CERTIFICATES (NEUROSURGERY) • 1. Intracranial Aneurysms and Vascular Neuroanatomy. 14-15 January 2017, Mersin (TNDer Neuroanatomy and Neurovascular Education Training Group). • 2. XII. International Turkish Spine Congress. 19-22 April 2017, Antalya (Turkish Spine Association). • 3. Certificate of Use of Experimental Animals. 10.12.2018 – 20.12.2018, Elazig (FÜSEM- Fırat University Continuing Education Center). • 4. Turkish Neurosurgery Academy 4th Scientific Conference. 1-4 November 2018, Adana. • 5. Turkish Neurosurgery Society Training Program 6.Semester 1.Module. 28.06.2018- 01.07.2018, Mudanya/Bursa. (Spinal and Peripheral Nerve Surgery Group). • 6. Turkish Neurosurgery Association Training Program 7.Semester 2.Module 27.06.2019 – 30.06.2019, Van. (Spinal and Peripheral Nerve Surgery Group). • 7. Turkish Neurosurgery Association Training Program 8th Term 1st Course 2-5 May 2019, Kayseri. (Pediatric Neurosurgery Teaching and Training Group). • 8. Current Developments in Gamma Knife Radiosurgery. 30.11.2019, Elazig. (Koç University Faculty of Medicine Prof. Dr. Selçuk Peker) • 9. Turkish Neurosurgery Society 25. Spinal Symposium 28-31 October 2021, Çeşme. (Spinal and Peripheral Nerve Surgery Group) • 10. Turkish Neurosurgery Society, 34. Scientific Congress. September 30 - October 3, 2021, Online • 11. Turkish Neurosurgery Association, NOVA 19-22 May, 2022, Kütahya. (Speaker) • 12. Spinal Deformity Correction Maneuvers Course 21 May 2022, Eskişehir. (Speaker) • 13. Turkish Neurosurgery Society, 35. Scientific Congress. 24 – 27 November 2022, Antalya. (Speaker) • 14. Complex Spinal Surgery, February 4, 2023, Eskişehir (Speaker). • 15. I worked as a fellow in the Pediatric Neurosurgery department of Catholica University (Rome/Italy) Agostino Gemelli Hospital between 15.01.2020 and 14.02.2020 for 1 month. ORAL PRESENTATIONS(2) • Surme MB, Ertugrul B, Sen D, Kaplan M. Is There a Genetic Link Between Meningioma and Acute Lymphoblastic Leukemia? A Case Presentation Involving the Analysis of 3 Genes. 33rd Scientific Congress of the Turkish Neurosurgery Congress. April 11-14, 2019, Antalya. • Ozturk S, Surme MB, Gönen M, Yıldırım H, Korkmaz S, Kocabıçak E. Analysis of Perfusion Changes in White and Grey Matter in Parkinson's Patients Treated with Subthalamic Nucleus Deep Brain Stimulation. 34th Scientific Congress of the Turkish Neurosurgery Congress. September 30 - October 3, 2021, Online." • "Surme MB, Ustun ME. Case of Vertebrobasilar Insufficiency Due to Vertebral Artery Dolichoarteriopathy. NOVA 2022, Kütahya." • "Ustun ME, Surme MB. Can vertebrobasilar insufficiency lead to parkinson like symptoms? EANS 2022, Belgrade." • "Ustun ME, Surme MB. Do vertebral artery stenoses have an atherosclerotic origin? EANS 2022, Belgrade." • "Surme MB, Yilmaz AH, Ustun ME. Could Resistant Urinary Incontinence Be Related to Vertebrobasilar Insufficiency? Our Initial Case Experiences. 31st National Urology Congress. October 27-30, 2022, Cyprus." • "Surme MB, Akgün B, Isci M, Baloglu M, Millet H. Evaluation of the Effectiveness of Surgical Approaches to Cervical Spondylotic Myelopathy on Cervical Spinal Canal Diameter and T2 Signal Intensity. 35th Scientific Congress of the Turkish Neurosurgery Congress. November 24 – 27, 2022, Antalya. • Surme MB, Cosar A, Daltaban IS, Ustun ME. Efficacy of a New Surgical Technique for Carotid Artery * "Surme MB, Arikan E, Baloglu M, Millet H, Ercan S. Analysis of Clinical and Radiological Findings in Cases November 24 – 27, 2022, Antalya. • "Surme MB, Cosar A, Ustun ME. Can Vertebrobasilar Insufficiency Cause Parkinson-like Symptoms? 35th Scientific Congress of the Turkish Neurosurgery Congress. November 24 – 27, 2022, Antalya. Diagnosed with Spontaneous Intracerebral Hematoma. 35th Scientific Congress of the Turkish Neurosurgery Congress. Dolichoarteriopathies in Patients with Moderate Hemiparesis due to Cerebrovascular Ischemic Attacks. 35th Scientific Congress of the Turkish Neurosurgery Congress. November 24 – 27, 2022, Antalya." • "Baloglu M, Millet H, Ercan S, Surme MB, Yayla E. The Effect of MCI-186 on Lipid Peroxidation in Rats with Experimental Traumatic Brain Injury. 35th Scientific Congress of the Turkish Neurosurgery Congress. November 24 – 27, 2022, Antalya." * "Surme MB, Ustun ME. Can Quantitative ElectroCorticoGraphy (ECoG) Be More Valuable Than Non -Quantitative ECoG? A Preliminary Report. Bridging Neurosciences and Neurosurgery: New Frontiers in Intraoperative Neurophysiology. February 2 – 4, 2023, Verona, Italy

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
• Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Prof. Erkan Kaptanoğlu, M.D. was born in Balikesir, Turkey in 1966. After completing his primary school, secondary school and high school education in Balikesir, he graduated from Istanbul University, Cerrahpasa Faculty of Medicine in 1990. He completed his internship at Peterborough District Hospital and Lincoln County Hospital in the United Kingdom. After a year of compulsory medical service, he completed his residency, which he had started in 1992, at Ankara Numune Training and Research Hospital in 1997 and became a Neurosurgery Specialist. After being assigned at the same hospital as Chief Resident in the same year, he studied “spinal cord injury and spinal cord regeneration” as a “research fellow” alongside Prof. Charles Tator, M.D., at the University of Toronto Faculty of Medicine in 1998-1999. After returning from Canada in 1999, he was tasked by the Ministry of Health to establish a Field Hospital and to work in cooperation with the Turkish Red Crescent Society at Hakkari, Şemdinli for two months. Following this assignment, he volunteered to work for the 1999 Marmara Earthquake relief effort.

He became an Associate Professor of Neurosurgery in 2004. He earned the title Doctor of Science (Ph.D.) by completing a doctorate program on Advanced Neuroscience between 2000-2005, at Hacettepe University Institute of Medical Sciences. He joined the project for autologous stem cell therapy in human spinal cord injuries with the Departments of Neurosurgery and Hematology at the Ankara University Faculty of Medicine. In 2009, he was appointed as Deputy Chief to the 1st Neurosurgery Clinic at the Ankara Numune Hospital, where he had been working.

At this hospital, in which he worked until 2010, he supervised and attended complex cranial, pediatric, spinal, trauma and vascular neurosurgery operations. He continued his academic research at Ankara University, Department of Anatomy and research laboratories of Ankara University and Hacettepe University for the purpose of developing strategies for complex spinal surgery operations.

With his research on spinal cord injuries and spinal anatomy, he won many awards such as the Acibadem Hospital Medical Research Award, 1st Place in 2000, Turkish Neurosurgical Society Dr. Mahir Tevruz Scientific Research Award, Tübitak and Brain Research Society Wheyt Award in 2001, Turkish Neurosurgical Society Hamit Ziya Gokalp Young Neurosurgeons Research Award, 2nd Place in 2002, Turkish Neurosurgical Society Yildiz Yalcinlar Scientific Research Award in 2004.

In 2010, he went to Cyprus to found the Near East University Faculty of Medicine Hospital with the guidance of Hacettepe University, and was appointed as full Professor. Between 2010-2015, he served as the Founder and Head of Department at the Near East University and Founder and Deputy Chief Physician at the University Training and Research Hospital in TRNC.

In 2000-2001, he served as a member of the editorial board for Türk Nöroşirurji Dergisi and Turkish Neurosurgery journal. Between the years 2001-2006, he served as an assistant editor for Türk Nöroşirurji Dergisi and Turkish Neurosurgery journals. In 2002-2003, he served as the Chairman of the Young Neurosurgeons Committee under the Turkish Neurosurgical Society. He was elected to the Turkish Neurosurgical Society Spinal and Peripheral Nerve Surgery Group Board of Directors to serve between 2003-2009. In 2013, he was again elected as a member to the Turkish Neurosurgical Society Spinal and Peripheral Nerve Surgery Group Board of Directors. In 2015, he became the Chairman of the Turkish Neurosurgical Society Spinal and Peripheral Nerve Surgery Group Board of Directors. In 2018, he was elected as a member to the Board of Turkish Neurosurgery Academy.

In 2015, he was appointed to the Marmara University Faculty of Medicine, Department of Neurosurgery and was elected as the Head of Department. During the same period, he also served as the Director of the Institute of Neuroscience. In 2018, he completed his tenure as the Head of Department. Reaching the end of this tenure in 2019, he retired from his duties as the Director of the Institute of Neuroscience and as a Member of the Faculty of Medicine. During his tenure at Marmara University, he supervised and accompanied surgical operations for complex cases from cranial patients to brain tumors (gliomas, meningiomas and hypophysis adenomas in particular), cerebral hemorrhages, Parkinson’s disease, trauma and vascular neurosurgery. He performed complex spinal surgery operations such as surgeries for spinal deformities (e.g. scoliosis and kyphosis), thoracoscopic spinal surgeries and sacral tumor surgeries. He conducted research and experimental studies on stem cell therapy and regeneration in spinal cord injuries. Between 2019-2020, currently He continues his clinical practice and surgeries along with his local and international academic studies, from his private clinic and Istanbul Brain and Spine Center.

He has attended numerous national and international courses and meetings as an instructor and speaker, was a guest speaker in over 100 events and conferences. He has published 65 international, 35 national scientific articles, edited 7 books, written 52 book chapters. He has served in the organizational committee 5 times in international meetings and 22 times in national meetings.

He is a member of the Turkish Medical Association, Turkish Cypriot Medical Association, Turkish Neurosurgical Society, Turkish Spine Society, EUROSPINE, AO Spine, Turkish Neurosurgery Academy.

Work and Interest Areas

• Peripheral Arterial Diseases
• Neurovascular Interventions
• Oncologic Interventions
• Nonvascular Interventions

Education

• (2004 – 2011), Faculty of Medicine, Inonu University, Malatya, Turkey
• (2011 – 2015), Department of Radiology, Bagcilar Training and Research Hospital, Istanbul, Turkey

Experience

• (2016 – 2020), Diagnostic and Interventional Radiologist, Mus State Hospital, Mus, Turkey
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology, Sakarya University Training and Research Hospital, Sakarya, Turkey
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology, Sakarya University Training and Research Hospital, Sakarya, Turkey
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology, Medipol University Hospital, Istanbul, Turkey

Memberships in Scientific Organizations

• TSIR (Turkish Society of Interventional Radiology)
• TSR (Turkish Society of Radiology)
• CIRSE (Cardiovascular and Interventional Radiological Society of Europe)
• ESR (European Society of Radiology)
• ESNR (European Society of Neuroradiology)

Specializations

Brain Tumors

Aneurysm Surgery

Pituitary Surgery

Spine Surgery

Waist neck and back hernias

Spine Tumors

Spinal Fractures

Peripheral Nerve Surgery

Specializations

Micro Surgical Lumbar and Cervical Disc Herniation Treatment

Scoliosis Surgery and Treatment

Brain and Spine Tumors

Spine Fracture Treatment

Spinal Canal Narrowing Surgery

Lumbar Slipping Surgery and Treatment

Specializations

Endoscopic Closed Lumbar Disc Herniation Surgery

Surgical Treatment for Spine Fractures

Minimally Invasive Surgery for Cervical and Lumbar Herniations

Education and Specialization:

• Medical Degree: Istanbul University Cerrahpaşa Faculty of Medicine (1991-1998)
• Specialization in Neurosurgery: Karadeniz Technical University Faculty of Medicine (1999-2005)
• Associate Professorship: (2015)
• Professorship: (2020)

Professional Experience:

• 2007-2008: Ankara GATA
• 2009-2011: Özel Ordu Medical Park Hospital
• 2011-2013: Ankara Keçiören Training and Research Hospital
• 2013-2015: Giresun University Faculty of Medicine
• 2014: Clinical Observer at Helsinki University Central Hospital
• 2015-2023: Karadeniz Technical University Faculty of Medicine
• Current Position: Neurosurgeon at VM Medical Park Pendik Hospital

Areas of Expertise:

• Brain Aneurysm and Repair
• Brain Tumor/Cancer Surgery
• Spinal Canal Stenosis Surgery
• Lumbar and Cervical Disc Herniation
• Spinal Cord Surgery
• Minimally Invasive Neurosurgery
• Pediatric Neurosurgery
• Congenital Anomalies

Research and Publications: Prof. Dr. Arslan has numerous publications in prestigious journals, covering topics such as the treatment of brain and spinal tumors, innovative neurosurgical techniques, and outcomes of neurosurgical interventions. His work includes studies on brain ischemia/reperfusion injury, spinal cord ischemia, and various other neurosurgical conditions.

Professional Memberships:

• Turkish Neurosurgery Association
• Turkish Society of Neurological Surgery

Education and Specialization:

• Medical Degree: Hacettepe University Faculty of Medicine (1981)
• Specialization in Neurosurgery: Kocaeli University Faculty of Medicine, Neurosurgery Department

Professional Experience:

• 1994-1998: Associate Professor and Head of the Neurosurgery Department, Kocaeli University
• 1998-Present: Professor and Head of the Neurosurgery Department, Kocaeli University
• Current Position: Neurosurgeon at VM Medical Park Pendik Hospital

International Experience:

• 1993: Observer at The Midland Centre for Neurosurgery and Neurology, Birmingham, UK
• Trained in syringomyelia and stereotactic neurosurgery under Bernard Williams, M.D., and Edward R. Hitchcock, M.D.

Clinical Experience:

• Performed over 5629 endoscopic surgeries including:
  • 4384 Pituitary Adenomas
  • 209 Rathke's Cleft Cysts
  • 152 Craniopharyngiomas
  • 121 Chordomas/Chondrosarcomas
  • 98 Tuberculum Sellae Meningiomas and other pathologies in the sellar region

Research and Publications: Prof. Dr. Savaş Ceylan has numerous publications in internationally recognized journals, covering a wide range of neurosurgical topics. His research includes pioneering work in endoscopic transsphenoidal surgery for pituitary tumors and other sellar region pathologies.

Professional Memberships:

• American Association of Neurological Surgeons (AANS)
• Congress of Neurological Surgeons (CNS)
• Academia Eurasiana Neurochirurgica
• International Federation of Neurosurgical Societies (IFNE)
• World Federation of Neurosurgical Societies (WFNS) Skull Base Committee
• Turkish Neurosurgery Association
• Turkish Society of Nervous System Surgery

Awards:

• 2016 Turkish Neurosurgery Association Service Award
• Scientific Publication Awards from Kocaeli University